Oppenheimer Asset Management’s FibroGen FGEN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2021
Q2 | – | Sell |
-377
| Closed | -$327K | – | 1211 |
|
|
2021
Q1 | $327K | Sell |
377
-10
| -3% | -$8.67K | 0.01% | 1011 |
|
|
2020
Q4 | $359K | Sell |
387
-286
| -42% | -$265K | 0.01% | 956 |
|
|
2020
Q3 | $692K | Buy |
673
+209
| +45% | +$215K | 0.01% | 720 |
|
|
2020
Q2 | $470K | Buy |
464
+4
| +0.9% | +$4.05K | 0.01% | 811 |
|
|
2020
Q1 | $400K | Sell |
460
-9
| -2% | -$7.83K | 0.01% | 798 |
|
|
2019
Q4 | $502K | Buy |
469
+49
| +12% | +$52.4K | 0.01% | 815 |
|
|
2019
Q3 | $388K | Sell |
420
-8
| -2% | -$7.39K | 0.01% | 864 |
|
|
2019
Q2 | $483K | Buy |
428
+38
| +10% | +$42.9K | 0.01% | 824 |
|
|
2019
Q1 | $530K | Buy |
+390
| New | +$530K | 0.01% | 789 |
|
|
2018
Q3 | – | Sell |
-151
| Closed | -$236K | – | 1152 |
|
|
2018
Q2 | $236K | Buy |
+151
| New | +$236K | 0.01% | 1026 |
|
|
2018
Q1 | – | Sell |
-176
| Closed | -$237K | – | 1143 |
|
|
2017
Q4 | $237K | Hold |
176
| – | – | 0.01% | 999 |
|
|
2017
Q3 | $237K | Buy |
176
+93
| +112% | +$125K | 0.01% | 1004 |
|
|
2017
Q2 | $67K | Sell |
83
-52
| -39% | -$42K | ﹤0.01% | 1282 |
|
|
2017
Q1 | $83K | Buy |
+135
| New | +$83K | ﹤0.01% | 1237 |
|